Business ❯Pharmaceutical Companies

Eli Lilly

Novo Nordisk Mounjaro Product Portfolio Stock Market Stock Prices GLP-1 Market Products Stock Price Sales Revenue Diabetes Drugs Eli Lilly Stock Zepbound Earnings Manufacturing Capacity Drug Approval Process Drug Shortages Financial Performance Mounjaro Drug

Ozempic Shows Promise Beyond Diabetes Treatment

New studies suggest potential benefits for dementia, addiction, and cardiovascular health.

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Eli Lilly and Amazon Partner to Deliver Weight Loss Drug Zepbound Directly to Consumers

Eli Lilly's Weight-Loss Drug Zepbound and Diabetes Treatment Mounjaro Drive Record Earnings

Tirzepatide Shows Promising Results in Lowering Blood Pressure Among Obese Adults